Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
- PMID: 33259154
- PMCID: PMC7722690
- DOI: 10.1056/NEJMc2031670
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Figures

Comment in
-
Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now.Radiol Imaging Cancer. 2021 Jan 22;3(1):e210003. doi: 10.1148/rycan.2021210003. eCollection 2021 Jan. Radiol Imaging Cancer. 2021. PMID: 33778764 Free PMC article. No abstract available.
Similar articles
-
Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia.Bone Marrow Transplant. 2021 Mar;56(3):716-719. doi: 10.1038/s41409-020-01059-y. Epub 2020 Sep 18. Bone Marrow Transplant. 2021. PMID: 32943755 No abstract available.
-
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.J Infect Chemother. 2021 Feb;27(2):387-389. doi: 10.1016/j.jiac.2020.12.001. Epub 2020 Dec 4. J Infect Chemother. 2021. PMID: 33328135 Free PMC article.
-
Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu.Allergy. 2021 Mar;76(3):918-921. doi: 10.1111/all.14609. Epub 2020 Oct 18. Allergy. 2021. PMID: 33012003 Free PMC article. No abstract available.
-
Prolonged shedding of SARS-CoV-2 in COVID-19 infected hemodialysis patients.Ther Apher Dial. 2021 Jun;25(3):356-358. doi: 10.1111/1744-9987.13566. Epub 2020 Sep 1. Ther Apher Dial. 2021. PMID: 32713131 No abstract available.
-
Three COVID-19 cases with a long-term viral shedding period in Tunisia.Pan Afr Med J. 2020 Jul 16;35(Suppl 2):117. doi: 10.11604/pamj.supp.2020.35.2.24950. eCollection 2020. Pan Afr Med J. 2020. PMID: 33282072 Free PMC article.
Cited by
-
Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now.Radiol Imaging Cancer. 2021 Jan 22;3(1):e210003. doi: 10.1148/rycan.2021210003. eCollection 2021 Jan. Radiol Imaging Cancer. 2021. PMID: 33778764 Free PMC article. No abstract available.
-
Use of convalescent plasma in COVID-19 patients with immunosuppression.Transfusion. 2021 Aug;61(8):2503-2511. doi: 10.1111/trf.16525. Epub 2021 Jun 1. Transfusion. 2021. PMID: 34036587 Free PMC article. Review.
-
Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates.medRxiv [Preprint]. 2021 Jun 25:2021.05.28.21258011. doi: 10.1101/2021.05.28.21258011. medRxiv. 2021. Update in: Clin Infect Dis. 2022 Aug 24;75(1):e1028-e1036. doi: 10.1093/cid/ciab968. PMID: 34100024 Free PMC article. Updated. Preprint.
-
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy.Eur J Cancer. 2021 Apr;147:154-160. doi: 10.1016/j.ejca.2021.01.033. Epub 2021 Feb 10. Eur J Cancer. 2021. PMID: 33676266 Free PMC article.
-
Insights into SARS-CoV-2 Persistence and Its Relevance.Viruses. 2021 May 29;13(6):1025. doi: 10.3390/v13061025. Viruses. 2021. PMID: 34072390 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention. Discontinuation of transmission-based precautions and disposition of patients with COVID-19 in healthcare settings (interim guidance). August 10, 2020. (https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-p...).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous